Armistice Capital, LLC Rockwell Medical, Inc. Transaction History
Armistice Capital, LLC
- $6.56 Billion
- Q1 2025
A detailed history of Armistice Capital, LLC transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 2,366,144 shares of RMTI stock, worth $2.58 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,366,144
Previous 3,043,678
22.26%
Holding current value
$2.58 Million
Previous $6.21 Million
56.95%
% of portfolio
0.04%
Previous 0.09%
Shares
12 transactions
Others Institutions Holding RMTI
# of Institutions
53Shares Held
7.01MCall Options Held
92.8KPut Options Held
14.9K-
Vanguard Group Inc Valley Forge, PA1.21MShares$1.31 Million0.0% of portfolio
-
Globeflex Capital L P San Diego, CA743KShares$810,1490.08% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny453KShares$493,7710.0% of portfolio
-
Marshall Wace, LLP London, X0334KShares$363,6180.0% of portfolio
-
Geode Capital Management, LLC Boston, MA325KShares$353,7470.0% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $11.6M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...